Excedrin PM Triple Action Caplets (GlaxoSmithKline Consumer Healthcare Holdings (US) LLC)
Welcome to the PulseAid listing for the Excedrin PM Triple Action Caplets drug offered from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| NON-PROPRIETARY NAME: | Acetaminophen, Aspirin (NSAID) and Diphenhydramine Citrate |
| SUBSTANCE NAME: | ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 2014-09-24 |
| END MARKETING DATE: | 0000-00-00 |
Excedrin PM Triple Action Caplets HUMAN OTC DRUG Details:
| Item Description | Excedrin PM Triple Action Caplets from GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| LABELER NAME: | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250; 250; 38(mg/1; mg/1; mg/1) |
| START MARKETING DATE: | 2014-09-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0067-2056_27db3313-8091-4d57-9028-5db85e7953ca |
| PRODUCT NDC: | 0067-2056 |
| APPLICATION NUMBER: | part343 |
Other ACETAMINOPHEN; ASPIRIN; DIPHENHYDRAMINE CITRATE Pharmaceutical Manufacturers / Labelers:
